Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma | Haematologica
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach | JCO Precision Oncology
Immunofixation - an overview | ScienceDirect Topics
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
Gut-educated IgA plasma cells defend the meningeal venous sinuses | Nature
IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14)
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
All About Multiple Myeloma Test and Result Interpretations
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma
PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
Multiple Myeloma and the 4;14 Translocation - HealthTree for Myeloma
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels | Haematologica
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications
Multiple myeloma - The Lancet
Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download
Multiple Myeloma: Diagnosis and Treatment | AAFP
Multiple myeloma - Wikipedia
The t(4;14) translocation and IgH-MMSET hybrid RT-PCR assays. (A)... | Download Scientific Diagram
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
